Vidofludimus

Vidofludimus
Legal status
Legal status	Investigational;
Identifiers
	IUPAC name 2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid;
CAS Number	1034190-08-3;
PubChem CID	9820008;
DrugBank	DB15446;
ChemSpider	7995757;
UNII	GHG2B47067;
ChEMBL	ChEMBL197194;
CompTox Dashboard (EPA)	DTXSID50431325 ;
ECHA InfoCard	100.112.872
Chemical and physical data
Formula	C20H18FNO4
Molar mass	355.365 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F;
	InChI InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25); Key:XPRDUGXOWVXZLL-UHFFFAOYSA-N;

Vidofludimus is an investigational new drug that is being evaluated to treat Crohn's disease and ulcerative colitis.^[1] It is a dihydroorotate dehydrogenase inhibitor.^[2]

References

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Legal status

Legal status	Investigational
Identifiers
IUPAC name 2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid
CAS Number	1034190-08-3
PubChem CID	9820008
DrugBank	DB15446
ChemSpider	7995757
UNII	GHG2B47067
ChEMBL	ChEMBL197194
CompTox Dashboard (EPA)	DTXSID50431325
ECHA InfoCard	100.112.872
Chemical and physical data
Formula	C₂₀H₁₈FNO₄
Molar mass	355.365 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F
InChI InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25) Key:XPRDUGXOWVXZLL-UHFFFAOYSA-N